Get the Stockscreener App
1.365
3.52%
-0.055
Caribou Biosciences Inc stock is traded at $1.365, with a volume of 309.18K.
It is down -3.52% in the last 24 hours and down -26.74% over the past month.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
See More
Previous Close:
$1.42
Open:
$1.41
24h Volume:
309.18K
Relative Volume:
0.19
Market Cap:
$128.58M
Revenue:
$34.48M
Net Income/Loss:
$-102.07M
P/E Ratio:
-0.9349
EPS:
-1.46
Net Cash Flow:
$-104.90M
1W Performance:
-4.20%
1M Performance:
-26.74%
6M Performance:
-27.89%
1Y Performance:
-78.99%
1-Day Range:
$1.35
$1.42
1-Week Range:
$1.34
$1.49
52-Week Range:
$1.30
$8.33
Caribou Biosciences Inc Stock (CRBU) Company Profile
Name
Caribou Biosciences Inc
Sector
Industry
Phone
510-982-6030
Address
2929 7TH STREET, SUITE 105, BERKELEY
Compare CRBU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.365 | 128.58M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.36 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
716.48 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
653.08 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.18 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.95 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-08-23 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-31-23 | Initiated | Evercore ISI | Outperform |
| Jul-11-23 | Initiated | Truist | Buy |
| Feb-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Dec-01-21 | Initiated | Oppenheimer | Outperform |
| Nov-30-21 | Initiated | H.C. Wainwright | Buy |
| Nov-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Aug-17-21 | Initiated | BofA Securities | Buy |
| Aug-17-21 | Initiated | Citigroup | Neutral |
| Aug-17-21 | Initiated | SVB Leerink | Outperform |
View All
Caribou Biosciences Inc Stock (CRBU) Latest News
Caribou Biosciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your RightsCRBU - PR Newswire
Investors who lost money on Caribou Biosciences, Inc.(CRBU) - GlobeNewswire
Investors who lost money on Caribou Biosciences, Inc.(CRBU) should contact The Gross Law Firm about pending Class ActionCRBU - PR Newswire
Caribou Biosciences, Inc. (NASDAQ:CRBU) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesCRBU - PR Newswire
Investing in Caribou Biosciences Inc (CRBU) Is Getting More Attractive - Knox Daily
Ratios Revealed: Decoding Caribou Biosciences Inc (CRBU)’s Financial Health - The Dwinnex
A stock that deserves closer examination: Caribou Biosciences Inc (CRBU) - US Post News
CRBU Stockholders Have Opportunity to Lead Caribou Biosciences, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - yourbigsky.com
Caribou Biosciences, Inc. Securities Fraud Class Action Lawsuit - GuruFocus.com
Caribou Biosciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your RightsCRBU - PR Newswire
Caribou Biosciences, Inc. (NASDAQ:CRBU) Receives $10.33 Consensus Price Target from Analysts - Defense World
CRBU Stock News: Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the Caribou Biosciences, Inc. Class Action - PR Newswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Caribou - GlobeNewswire
2025-02-03 | Shareholders That Lost Money on Caribou Biosciences, Inc. (CRBU) Urged to Join Class ActionContact Levi & Korsinsky to Learn More | NDAQ:CRBU | Press Release - Stockhouse Publishing
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Caribou Biosciences, Inc. Investors to Secure - The Bakersfield Californian
Class Action Filed Against Caribou Biosciences, Inc. (CRBU) - GlobeNewswire
CRBU’s Market Fluctuations: Is Now the Right Time to Invest? - The InvestChronicle
2025-02-03 | Levi & Korsinsky Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025CRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
Sriram Ryali Acquires 17,360 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) Stock - MarketBeat
2025-02-02 | Investors who lost money on Caribou Biosciences, Inc.(CRBU) should contact Levi & Korsinsky about pending Class ActionCRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
2025-02-02 | Levi & Korsinsky Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025CRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - PR Newswire
2025-02-02 | Levi & Korsinsky Notifies Shareholders of Caribou Biosciences, Inc.(CRBU) of a Class Action Lawsuit and an Upcoming Deadline | NDAQ:CRBU | Press Release - Stockhouse Publishing
2025-02-01 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. LawsuitCRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit - PR Newswire
Caribou Biosciences stock hits 52-week low at $1.32 - MSN
Caribou Biosciences stock hits 52-week low at $1.32 By Investing.com - Investing.com South Africa
Contact Levi & Korsinsky by February 24, 2025 Deadline to Join Class Action Against Caribou Biosciences, Inc.(CRBU) - Stockhouse Publishing
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) - GuruFocus.com
2025-01-29 | Levi & Korsinsky Notifies Shareholders of Caribou Biosciences, Inc.(CRBU) of a Class Action Lawsuit and an Upcoming Deadline | NDAQ:CRBU | Press Release - Stockhouse Publishing
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - GlobeNewswire
2025-01-29 | Investors who Lost Money on Caribou Biosciences, Inc. (CRBU) Should Contact Levi & Korsinsky About Pending Class ActionCRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
CRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou - GlobeNewswire
2025-01-28 | Investors in Caribou Biosciences, Inc. Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your RightsCRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesCRBU - PR Newswire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Caribou - GlobeNewswire
Shareholders that lost money on Caribou Biosciences, Inc. - GlobeNewswire
The Gross Law Firm Notifies Shareholders of Caribou Biosciences, Inc.(CRBU) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
FY2025 Earnings Estimate for CRBU Issued By Leerink Partnrs - Defense World
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Sold by JPMorgan Chase & Co. - Defense World
TOP RANKED ROSEN LAW FIRM Encourages Caribou Biosciences, - GlobeNewswire
TOP RANKED ROSEN LAW FIRM Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Leerink Partnrs Has Negative Outlook of CRBU FY2025 Earnings - MarketBeat
Caribou Biosciences stock hits 52-week low at $1.49 By Investing.com - Investing.com Australia
Equities Analysts Offer Predictions for CRBU FY2025 Earnings - Defense World
Caribou Biosciences stock hits 52-week low at $1.49 - MSN
Analysts Offer Predictions for CRBU FY2025 Earnings - MarketBeat
Caribou Biosciences Inc Stock (CRBU) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):